Loading…
Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration
The pharmacokinetics and intramuscular (i.m.) bioavailability of cefoperazone and cefamandole (20 mg/kg) were investigated in dogs and the findings related to minimal inhibitory concentrations (MICs) for 90 bacterial strains isolated clinically from dogs. The MICs of cefamandole for Staphylococcus i...
Saved in:
Published in: | The veterinary journal (1997) 2003-09, Vol.166 (2), p.170-176 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The pharmacokinetics and intramuscular (i.m.) bioavailability of cefoperazone and cefamandole (20
mg/kg) were investigated in dogs and the findings related to minimal inhibitory concentrations (MICs) for 90 bacterial strains isolated clinically from dogs. The MICs of cefamandole for
Staphylococcus intermedius (MIC
90 0.125
μg/mL) were lower than those of cefoperazone (MIC
90 0.5
μg/mL) although the latter was more effective against
Escherichia coli strains (MIC
90 2.0
μg/mL vs. 4.0
μg/mL).
The pharmacokinetics of the drugs after intravenous administrations were similar: a rapid distribution phase was followed by a slower elimination phase (
t
(1/2)
λ2
84.0±21.3
min for cefoperazone and 81.4±9.7
min for cefamandole). The apparent volume of distribution and body clearance were 0.233
L/kg and 1.96
mL/kg/min for cefoperazone, 0.190
L/kg and 1.76
mL/kg/min for cefamandole. After i.m. administration the bioavailability and peak serum concentration of cefamandole (85.1±13.5% and
35.9±5.4
μg/
mL
) were significantly higher than cefoperazone (41.4±7.1% and
24.5±3.0
μg/
mL
), but not the serum half-lives (
t
1/2el 134.3±12.6
min for cefoperazone and 145.4±12.3
min for cefamandole). The time above MIC
90 indicated that cefamandole can be administered once daily to dogs for the treatment of staphylococcal infections (
T>MIC for
S. intermedius 23.8±0.3 and for
Staphylococcus aureus 21.6±0.6
h). |
---|---|
ISSN: | 1090-0233 1532-2971 |
DOI: | 10.1016/S1090-0233(03)00051-0 |